Bg pattern

GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Glycophos 216 mg/ml concentrate for solution for infusion

Sodium glycerophosphate

Read all of this leaflet carefully before you start using this medicine because it contains important information for you:

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What is Glycophos and what is it used for
  2. What you need to know before you use Glycophos
  3. How to use Glycophos
  4. Possible side effects
  5. Storage of Glycophos
  6. Contents of the pack and further information

1. What is Glycophos and what is it used for

Glycophos is a concentrate for solution for infusion, which belongs to the group of medicines called electrolyte solutions, additives for intravenous solutions.

Glycophos is indicated in adult and child patients as a supplement in intravenous nutrition to cover phosphate needs.

Glycophos is a medicine that will be administered to you by a doctor or healthcare professional.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Glycophos

Do not use Glycophos:

  • if you are allergic (hypersensitive) to sodium glycerophosphate or any of the other ingredients of this medicine.
  • if you are in a state of dehydration, hypernatremia (high sodium levels in the blood) or hyperphosphatemia (high phosphate levels in the blood).
  • if you have severe renal failure or are in a state of shock.

Warnings and precautions

Consult your doctor before starting to use this medicine. If you have renal failure, your doctor will regularly monitor your blood phosphate levels.

Glycophos can only be added to or mixed with other medicinal products whose compatibility has been documented.

Glycophos must not be administered undiluted.

Use of other medicines:

No interactions with other medicines have been observed, although a moderate decrease in serum phosphate has been seen during carbohydrate infusions.

Note that these instructions may also apply to medicines that you have taken before or may take later.

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription.

Pregnancy and breastfeeding:

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

There are limited or no data on the use of Glycophos in pregnant women.

The use of Glycophos during pregnancy may be considered in cases where it is clinically indicated.

Driving and using machines:

It is not known whether Glycophos has any effects on the ability to drive and use machines.

3. How to use Glycophos

Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.

Adults:

The recommended dosage is individual. The recommended daily dose of phosphate during intravenous nutrition is about 10-20 mmol. This can be achieved by adding 10-20 ml of Glycophos to the infusion solution or to a mixture whose compatibility has been checked.

Children:

The recommended dosage is individual. The recommended dose for children and newborns is 1.0-1.5 mmol/kg body weight/day.

The solution will be administered by intravenous infusion. Before use, check that the solution is homogeneous and that the vial is not damaged.

If you use more Glycophos than you should:

No adverse effects have been observed due to overdosing. Most patients in need of intravenous nutrition have an increased ability to tolerate glycerophosphates.

In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service. Telephone 915 620 420, indicating the medicine and the amount used.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Glycophos can cause side effects, although not everybody gets them.

No adverse reactions related to glycerophosphates have been reported.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Glycophos

Keep out of the sight and reach of children.

Store below 25°C. Do not freeze.

Do not use Glycophos after the expiry date which is stated on the carton after EXP. The expiry date is the last day of the month stated.

Do not use this medicine if you notice that the solution is not homogeneous or the vial is damaged.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and further information

Composition of Glycophos

  • The active substance is sodium glycerophosphate pentahydrate. One ml of Glycophos contains 306.1 mg of active substance (equivalent to 216 mg of anhydrous sodium glycerophosphate).
  • The electrolytes in 1 ml are phosphate (1 mmol) and sodium (2 mmol).
  • The other ingredients are hydrochloric acid (for pH adjustment) and water for injectable preparations.

Appearance and packaging

Concentrate for solution for infusion

Glycophos is a clear, colorless or pale yellow solution.

Glycophos is available in polypropylene vials and ampoules.

The packs contain 10 vials of 20 ml and 20 ampoules of 20 ml.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

Fresenius Kabi España S.A.U.

Marina 16-18

08005 Barcelona (Spain)

Manufacturer

HP Halden Pharma AS

Svinesundveiem 80

1788 Halden

Norway

Date of last revision of this leaflet:March 2020.

This information is intended only for healthcare professionals:

Practical information on preparation and/or handling of the medicinal product

Glycophos must not be administered undiluted.

Before use, check that the solution is homogeneous and that the vial is not damaged.

Compatibility

Additions must be made aseptically.

  • 120 ml of Glycophos and 48 mmol of calcium (CaCl2) can be added to 1000 ml of Vamin Glucosa, Vamin 14, Vamin 14 without electrolytes and Vamin 18 without electrolytes.
  • 10 ml of Glycophos and 10 mmol of calcium (CaCl2) can be added to 1000 ml of Glucose 50 mg/ml.
  • 20 ml of Glycophos and 20 mmol of calcium (CaCl2) can be added to 1000 ml of Glucose 200 mg/ml.
  • 60 ml of Glycophos and 24 mmol of calcium (CaCl2) can be added to 1000 ml of Glucose 500 mg/ml.

Infusion time

The infusion time must not be less than 8 hours.

Stability

When additions are made to an infusion solution, the infusion should be administered within 24 hours of preparation to prevent microbial contamination. The remaining contents of opened vials/ampoules should be discarded and not stored for later use.

Online doctors for GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION

Discuss questions about GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (5)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (1056)
Doctor

Andrei Popov

General medicine 7 years exp.

Dr. Andrei Popov is a family physician with specialized training in the management of chronic pain. He provides video consultations for adults in Spain and across Europe: whether you have been living with pain for months that no one has been able to properly explain, or you need to resolve a health issue without waiting weeks for an appointment.

His approach is clear: to listen, organize your case, and provide you with a practical roadmap based on evidence-based medicine and adapted to your medical history and personal needs.

Pain: how he can help

  • Chronic pain (more than 3 months
  • Migraine and recurrent or high-intensity headaches
  •  Neck, lower back, back and joint pain
  •  Post-traumatic pain after injuries or surgeries
  •  Pain of neurological origin: neuralgia, neuropathic pain, fibromyalgia

General medicine

  • Frequent respiratory infections (cold, flu, persistent cough)
  • Hypertension, diabetes and metabolic disorders
  • Review of laboratory tests and MRI/CT reports (explained in clear language)
  • Preventive medicine and health monitoring
  • Second opinions and treatment adjustments (when clinically appropriate)

What the consultation is like
 Each session lasts up to 30 minutes. We review symptoms, medical history, medications and any tests you provide, and you finish the consultation with a clear treatment plan, defined next steps, and criteria to understand when follow-up may be needed. If warning signs are detected, he will clearly advise whether you need in-person care or urgent medical attention.

Camera Book a video appointment
€80
0.0 (0)
Doctor

Joao Silva

General medicine 6 years exp.

Dr. João Silva is a physician with training and experience in the field of General and Family Medicine, dedicated to providing healthcare focused on the well-being and quality of life of his patients. Throughout his professional career, he has developed broad clinical competencies, striving to maintain a medical practice based on scientific evidence and continuous knowledge updates.

Between 2013 and 2019, he completed the Integrated Master's Degree in Medicine at the Abel Salazar Institute of Biomedical Sciences in Porto, where he acquired a solid academic and clinical education.

Subsequently, between January 2021 and December 2021, he completed the General Internship at the Entre Douro e Vouga Hospital Center in Santa Maria da Feira, where he had the opportunity to work in different hospital settings and deepen his competencies in several areas of medicine.

From January 2022 until March 2026, he works as a Resident Physician in General and Family Medicine at USF Salvador Machado in Oliveira de Azeméis, developing clinical activities in primary healthcare, follow-up of chronic patients, and health promotion in the community.

Complementing his medical training, Dr. João Silva also completed a Postgraduate Degree in Continuing and Palliative Care at CESPU, strengthening his preparation in the comprehensive approach to patient care, especially in situations requiring prolonged care and multidisciplinary support.

Camera Book a video appointment
€55

Frequently Asked Questions

Is a prescription required for GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
The active ingredient in GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION is sodium glycerophosphate. This information helps identify medicines with the same composition but different brand names.
Who manufactures GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION is manufactured by Fresenius Kabi España, S.A.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to GLYCOPHOS 216 mg/mL CONCENTRATE FOR INFUSION SOLUTION?
Other medicines with the same active substance (sodium glycerophosphate) include POTASSIUM ACETATE B.BRAUN 1 mEq/ml CONCENTRATE FOR INFUSION SOLUTION, SODIUM BICARBONATE 1/6 M MEIN SOLUTION FOR INFUSION, SODIUM BICARBONATE 1M GRIFOLS INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media